Coley Pharmaceutical Group discovered, developed and commercialized a new class of drugs that stimulate the human immune system to treat and prevent cancer, asthma, allergy, and infectious diseases.

The company was initially listed on NASDAQ and was subsequently acquired by Pfizer.

Company: coley
Fund: alpinvest
Status: Realized
Team member: Harrold van Barlingen
Technology: Therapeutics